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1. Outline of Doctoral Thesis 
 
DNA origami has been considered as a potentially important tool in nanotechnology for 
efficient delivery of drugs into a biological system. Nevertheless, prior to its application, DNA 
origami still faces outstanding challenges particularly in scalability and functionality. This 
doctoral thesis reports an attempt to address these challenges by establishing a novel DNA origami 
motif assembled from catenated ssDNA, called DNA topogami (scalability) and by producing a 
DNA origami scaffold able to selectively bind to Plasmodium falciparum lactate dehydrogenase 
(PfLDH), an important diagnostic indicator for all malaria-causing Plasmodium parasites. This 
opens the possibility for building more advanced and complex devices, with potential use as 
diagnostic tools and which may also provide the basis for drug delivery systems for malaria 
(functionality). 
In order to develop the novel DNA origami motif termed “DNA topogami”, topologically 
interlocked catemers were constructed using an M13mp18 DNA scaffold in a preliminary 
catenation step mediated by human ENA/VASP-like (EVL) protein and catalyzed by Escherichia 
coli topoisomerase I. Subsequent folding of the fabricated DNA catenanes with staple strands 
would enable the assembly of mechanically interlinked topological structures, larger in size than 
regular DNA origami tiles. In comparison to the existing scaling up approaches, DNA topogami 
promises to generate mechanically interconnected, robust structures assembled via a single set 
of staple strands, capable of folding each and every scaffold catena simultaneously, in a single 
one-pot reaction, therefore greatly reducing the cost of production. Additional advantages of 
this method include the possibility to finely tune the size of the assembly through adjusting the 
size of the scaffold during catenation. This is a significant advance considering that most existing 
scaling methods rely on using numerous sets of staples for the step-wise assembly of each 
integrated component. Moreover, step-wise techniques generate intrinsically weak superstructures, 
due to the fault line between the assembled structures and the weak nature of bonding between 
tiles. Structurally similar to the DNA origami concept, DNA topogami hold the advantage of 
coordinated scalability through exercising control over the degree of preliminary scaffold 
catenation. 
In order to address the functionality challenge, a DNA aptamer was incorporated into a DNA 
origami tile for the selective capturing and immobilization of PfLDH, an important diagnostic 
indicator for all malaria-causing Plasmodium parasites. While the incorporation of various 
proteins onto the DNA origami tile has been previously described, this was the first attempt to 
use PfLDH in conjunction with the aptamer modified DNA origami (AM-DNA origami) system, 
with the objective to engineer a device capable of detection and potential future drug delivery. 
The structural design was based on a standard DNA origami rectangle and employed aptamer 
sequences known to bind to PfLDH with high specificity and avidity. In order to incorporate 
these aptamers into DNA origami, a staple sequence complementary to part of the M13!DNA 
origami template strand was added at the 5"end of the aptamer. 12 modified aptamers were 
incorporated into the rectangle through 12 staple sequences complementary to M13!DNA at 
positions that formed a linear pattern along one edge of the DNA rectangle. Atomic force 
microscopy demonstrated that the incorporated aptamers preserved their ability to specifically 
bind target protein. Captured PfLDH retained enzymatic activity and protein-aptamer binding 
was observed dynamically using high-speed AFM. This work demonstrates the ability of DNA 
aptamers to recognize a malaria biomarker whilst being integrated within a supramolecular 
DNA scaffold, opening new possibilities for malaria diagnostic approaches based on DNA 
nanotechnology. Additionally, this system could be further developed into a smart drug delivery 
nanodevice containing a drug molecule that would be released for malaria treatment. The 
method of incorporation would depend on the nature of the drug and target molecules, being 
released only in the presence of disease related parasites. 
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2. Contents of the Doctoral Thesis Public Defense 
On the 13th of May 2016, a public defense was held as a follow-up to the preliminary 
defense, in order to validate the contents of the submitted doctoral thesis. The discussions, 
questions and answers presented during the public defense are listed below: 
1. A question was asked regarding the two-step assembly process where 12 staple strands were 
omitted from the DNA origami structure, and why the removal of those 12 staples did not 
affect the overall structural integrity of the origami tile. The candidate presented the 
following answer: DNA origami was folded with the aid of over 200 staple strands. 
Removing 12 oligonucleotides would not affect the overall structural integrity of the DNA 
origami tile. Although the intermediate partially folded DNA origami was not visualized via 
AFM, if imaged, a fully assembled DNA origami tile with a partially folded edge would be 
observed, due to the absence of 12 staples. The unfolded M13 strand would fully integrate 
into the origami tile structure upon addition of the 12 remaining staples. 
2. A question was made on how DNA origami could be used as a potential tool for malaria 
treatment in addition to its application in diagnostics. To answer this question, the candidate 
presented an example of a previously constructed DNA origami structure shaped as a 
hexagonal barrel. It was constructed from two domains linked covalently at the rear edge by 
DNA scaffold hinges, and closed at the front via an aptamer-based lock mechanism. Upon 
reacting with a set of antigen keys, the aptamers would act as entropic springs and 
reconfigure the barrel to give access to its interior surface, unloading the cargo. The barrel 
could be loaded in order to contain either a signaling or a drug molecule, which would be 
released either for diagnosis or treatment. 
3. The comments were made that if such DNA barrels were to be used, only several drug 
molecules would be delivered into the blood stream. It was asked whether that would be 
enough for treatment purposes. The candidate answered that this problem could be 
addressed by adjusting the concentration of the DNA origami solution. An alternative 
strategy would be to increase the size of the DNA origami barrel in order to accommodate a 
higher concentration of drug molecules. In general terms, the entire design of the DNA 
origami structure would have to be adjusted so as to fit the size of the drug molecules. 
Furthermore, the biodegradability of DNA origami in the blood stream was also discussed.   
4. Regarding further applications of this system, a question was asked about detecting the 
protein-aptamer binding reaction in areas with limited resources without access to AFM. 
The candidate answered that an easily observable signal would have to be developed, e.g. a 
colorimetric assay based on the intrinsic enzymatic activity of PfLDH. The results presented 
in this thesis show that PfLDH bound to AM-DNA origami retained enzymatic activity and 
was stable in the presence of human plasma. This will facilitate the future integration of the 
AM-origami protein system into nanometric devices capable of detection based on localized 
enzymatic activity. A more complex origami device may be able to encapsulate and 
separate molecules that produce a functional fluorophore only when they interact. In such a 
system, aptamers could actuate opening of the encapsulating DNA origami, allowing the 
molecules to interact and produce a fluorescent signal.  
5. A question was made on the merit of using DNA origami as a detection system. The 
candidate mentioned that as a diagnostic tool, DNA origami has advantages in simplicity of 
design and assembly, small size, addressability, programmability, and the ability to 
incorporate multiple copies of the same aptamer simultaneously, thereby enhancing 
detection sensitivity. Alternatively, it could incorporate several different aptamers for 
distinct ligands, thus increasing sophistication and subtlety of detection. The biggest 
limiting factor at the moment seems to be cost, however, this issue has not been considered 
from an engineering perspective. The volume necessary for detection lies in the microliter 
region, therefore, if production was to be scaled up and optimized, and the cost per reaction 
calculated, it could be that the expense is similar to the currently available detection options.  
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6. A question was asked about the binding on/off rates, specifically why the calculated Kds 
were high, yet HS-AFM results indicated towards strong binding affinity. The candidate 
answered that the calculated Kd corresponded to the aptamer modified staple strands prior 
to integration into the DNA origami tile, as the tile was too large to be run on the gel. 
Therefore, the exact binding Kd would differ based on the fact that non-interacting 
sequences at the termini of aptamers resulted in a decreased affinity for their targets, likely 
due to additional unwanted interactions, fact previously reported. Once those termini 
sequences were integrated into the DNA origami structure during assembly, the actual Kd 
would differ significantly from the calculated values, being expected to correspond to the 
original reported lower Kd values. 
7. A question was asked whether any publications were available showing DNA origami 
keeping its structural integrity and not being degraded in the blood stream. The candidate 
explained that the stability of DNA origami has been tested in cell lysates from various 
normal and cancerous cell lines, and the published papers reported DNA origami to retain 
its structural integrity. Additionally, the DNA could be separated from cell lysates without 
damage or degradation.    
8. A question was made whether HS-AFM required static or dynamic conditions. As the 
answer, the candidate mentioned that for imaging purposes the sample was added directly to 
the mica surface. However, the microscope contained a chamber to which buffer or proteins 
could be further added, therefore the system could be compared to a microfluidic device and 
the process considered dynamic, although sample could not be added to the mica surface 
itself without stopping the imaging process. 
 
Based on the explanations to the presented questions the candidate has provided sufficient 
answers and sound discussion to further allow the examiners to understand and interpret her 
doctoral thesis research. We believe that she has provided critical and new insights to the field 
of DNA Nanotechnology and believe that her contributions will assist in the advancement of 
this field. Additionally, the candidate has included the answers to the questions presented during 
the defense into the doctoral thesis, in order to allow future readers to better comprehend her 
research. Therefore, after severely evaluating the candidate’s doctoral thesis and her preliminary 
and public defense, we agree that the candidate has sufficient knowledge and should be awarded 
the Doctor of Science degree. 
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